-+ 0.00%
-+ 0.00%
-+ 0.00%

*Johnson & Johnson: sNDA Submitted to FDA for CAPLYTA as Adjunctive Treatment for Major Depressive Disorder >JNJ

Dow Jones·04/02/2025 12:44:00

Please log in to view news